Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Periplaneta americana extract helps hair regrowth in mice with alopecia.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

New hair products are being developed to keep hair and scalp healthy for everyone.

Mast cells might contribute to hair loss by causing skin thickening.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

Hormones and genes affect hair growth and male baldness.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.